Faricimab in Neovascular Age-Related Macular Degeneration: Week 48 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials

  • Karl G. Csaky, MD, PhD
  • Video
  • Published 2021

See more